老年人多社交可降低痴呆风险

2019-08-05 周舟 新华社

英国研究人员在新一期美国《科学公共图书馆·医学》杂志发表论文说,社交活跃的中老年人患痴呆症的风险更低。英国伦敦大学学院研究人员分析了超过1万人的生活与健康数据,他们在1985年到2013年间多次接受了社交状况调查和认知能力检测,有的健康数据还更新至2017年。结果显示,在60岁时几乎每天都与朋友会面的人,与隔几个月才与朋友会面的人相比,此后患痴呆症的风险要低12%。研究还显示,50岁和70岁时有较

英国研究人员在新一期美国《科学公共图书馆·医学》杂志发表论文说,社交活跃的中老年人患痴呆症的风险更低。

英国伦敦大学学院研究人员分析了超过1万人的生活与健康数据,他们在1985年到2013年间多次接受了社交状况调查和认知能力检测,有的健康数据还更新至2017年。结果显示,在60岁时几乎每天都与朋友会面的人,与隔几个月才与朋友会面的人相比,此后患痴呆症的风险要低12%。

研究还显示,50岁和70岁时有较多的社交活动,也与痴呆症风险下降有关联,不过这种关联在统计学上的显着性要低一些。研究人员认为,在任何年龄段的社交活动都有助于降低痴呆风险。

据介绍,此前已有研究显示社交活动较多与痴呆风险下降之间存在关联,但由于相关数据的时间跨度不够,难以排除受调查者是因为认知能力下降才减少社交活动的可能性,新研究中所用的长期跟踪数据能更好地支持社交活动有助降低痴呆风险的观点。

论文作者之一、伦敦大学学院教授吉尔·利文斯顿说,社交活动可以锻炼记忆和语言等认知能力,帮助大脑更好地应对衰老,与朋友聚会还能让身体多活动,这些都有助于老人减少罹患痴呆症的风险。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1316732, encodeId=da921316e3284, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Wed Aug 07 02:26:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603437, encodeId=f2c2160343ef4, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Wed Aug 07 02:26:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048551, encodeId=592d1048551f8, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Aug 05 14:26:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370807, encodeId=d7d73e080778, content=多参加社交活动,多动脑,都有好处。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Mon Aug 05 13:05:15 CST 2019, time=2019-08-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1316732, encodeId=da921316e3284, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Wed Aug 07 02:26:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603437, encodeId=f2c2160343ef4, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Wed Aug 07 02:26:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048551, encodeId=592d1048551f8, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Aug 05 14:26:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370807, encodeId=d7d73e080778, content=多参加社交活动,多动脑,都有好处。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Mon Aug 05 13:05:15 CST 2019, time=2019-08-05, status=1, ipAttribution=)]
    2019-08-07 fengyi818
  3. [GetPortalCommentsPageByObjectIdResponse(id=1316732, encodeId=da921316e3284, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Wed Aug 07 02:26:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603437, encodeId=f2c2160343ef4, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Wed Aug 07 02:26:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048551, encodeId=592d1048551f8, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Aug 05 14:26:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370807, encodeId=d7d73e080778, content=多参加社交活动,多动脑,都有好处。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Mon Aug 05 13:05:15 CST 2019, time=2019-08-05, status=1, ipAttribution=)]
    2019-08-05 junJUN

    老年人痴呆何药可用??

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1316732, encodeId=da921316e3284, content=<a href='/topic/show?id=d3d0e121576' target=_blank style='color:#2F92EE;'>#痴呆风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71215, encryptionId=d3d0e121576, topicName=痴呆风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a98f453, createdName=pcw106, createdTime=Wed Aug 07 02:26:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603437, encodeId=f2c2160343ef4, content=<a href='/topic/show?id=657ce391325' target=_blank style='color:#2F92EE;'>#社交#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73913, encryptionId=657ce391325, topicName=社交)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=004519034290, createdName=fengyi818, createdTime=Wed Aug 07 02:26:00 CST 2019, time=2019-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048551, encodeId=592d1048551f8, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Aug 05 14:26:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370807, encodeId=d7d73e080778, content=多参加社交活动,多动脑,都有好处。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Mon Aug 05 13:05:15 CST 2019, time=2019-08-05, status=1, ipAttribution=)]
    2019-08-05 130****4638

    多参加社交活动,多动脑,都有好处。

    0

相关资讯

Diabetes Care:新发2型糖尿病患者BMI、体重变化与痴呆风险

由此可见,较低的基线BMI与新发2型糖尿病患者全因痴呆和AD风险增加有关。糖尿病诊断后体重减轻或体重增加与全因痴呆的风险增加有关。体重减轻与AD风险增加有关。

JAMA Neurol:认知储备与痴呆风险

研究认为,积极参见并提高认知储备显著降低痴呆症风险有关,该效果甚至不受脑部神经退行性病变的影响。

JAHA:NOACs与华法林对房颤患者痴呆发生的影响

目前,非维生素K拮抗剂口服抗凝药(NOACs)能否减轻房颤患者的痴呆进展尚不清楚。本研究的目的旨在比较和评估NOACs和华法林对房颤患者痴呆进展的影响。本研究纳入了丹麦国家数据库中33617名接受口服抗凝药治疗的房颤患者,其中11052名患者年龄在60-69岁,13237名年龄在70-79岁,9238名年龄≥80岁。有约60%的患者服用NOACs治疗,40%的患者服用华法林。经过平均3.4年时间的

JAMA Neurol:他汀类药物可降低脑震荡老人后续痴呆风险

研究发现,他汀类药物可降低脑震荡老人后续痴呆风险

述评:轻度行为损害与痴呆相关研究的共识与争议

痴呆是一种以认知功能障碍和日常活动能力减退为主要表现的临床综合征。神经精神症状(neuropsychiatric syndrome,NPS)贯穿于痴呆的始终,是各种痴呆类型的主要表现之一,在不同类别的痴呆以及同一种痴呆的时期,其具体表现可能也不同。目前NPS分为轻度行为损害(mild behavioral impairment,MBI)和痴呆精神行为损害(BPSD)。NPS临床表现主要包括情绪/情

Eur Heart J:无卒中房颤患者的痴呆风险

由此可见,AF与痴呆风险增加有关,与老年人群的卒中无关。口服抗凝剂的使用与痴呆的发生率降低有关。